Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1: In vitro and in vivo studies

被引：0
|
作者：
Deacon, CF
Knudsen, LB
Johansen, NL
Madsen, K
Holst, JJ
机构：
[1] UNIV COPENHAGEN,PANUM INST,DEPT MED PHYSIOL,DK-2200 COPENHAGEN,DENMARK
[2] NOVO NORDISK AS,MALOV,DENMARK
来源：
DIABETOLOGIA | 1997年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [1] Synthesis and Bioactivity Evaluation of Dipeptidyl Peptidase IV Resistant Glucagon-like Peptide-1 Analogues
    Zhou, Jinpei
    Ni, Shuaijian
    Zhang, Huibin
    Qian, Hai
    Chi, Yushi
    Huang, Wenlong
    Yu, Lu
    Hu, Xiaowen
    Chen, Wei
    [J]. PROTEIN AND PEPTIDE LETTERS, 2010, 17 (10): : 1290 - 1295
  • [2] A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro
    Lambeir, AM
    Proost, P
    Scharpé, S
    De Meester, I
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 64 (12) : 1753 - 1756
  • [3] Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide-1
    Deacon, CF
    Hughes, TE
    Holst, JJ
    [J]. DIABETES, 1998, 47 : A69 - A69
  • [4] Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity
    C. F. Deacon
    L. B. Knudsen
    K. Madsen
    F. C. Wiberg
    O. Jacobsen
    J. J. Holst
    [J]. Diabetologia, 1998, 41 : 271 - 278
  • [5] Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity
    Deacon, CF
    Knudsen, LB
    Madsen, K
    Wiberg, FC
    Jacobsen, O
    Holst, JJ
    [J]. DIABETOLOGIA, 1998, 41 (03) : 271 - 278
  • [6] The degradation of glucagon-like peptide-1 involves both dipeptidyl peptidase IV and neutral endopeptidase 24.11 in vivo
    Plamboeck, A
    Holst, JJ
    Carr, RD
    Deacon, CF
    [J]. REGULATORY PEPTIDES, 2004, 122 (01) : 6 - 6
  • [7] Stability and Bioactivity Studies on Dipeptidyl Peptidase IV Resistant Glucogan-like Peptide-1 Analogues
    Chen, Wei
    Zhou, Yinghong
    Zhang, Huibin
    Qian, Hai
    Huang, Wenlong
    Yang, Baowei
    Han, Jing
    Zhou, Jingpei
    Chi, Yushi
    Ni, Shuaijian
    [J]. PROTEIN AND PEPTIDE LETTERS, 2012, 19 (02): : 203 - 211
  • [8] Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo
    Xiao, Q
    Giguere, J
    Parisien, M
    Jeng, W
    St-Pierre, SA
    Brubaker, PL
    Wheeler, MB
    [J]. BIOCHEMISTRY, 2001, 40 (09) : 2860 - 2869
  • [9] Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1
    Burcelin, R
    Dolci, W
    Thorens, B
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (02): : 252 - 258
  • [10] Drug evaluation: BIM-51077, a dipeptidyl peptidase-IV-resistant glucagon-like peptide-1 analog
    Giannoukakis, Nick
    [J]. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (10) : 842 - 848
12345